New COVID-19 vaccines: here's how the promising Novavax and Johnson & Johnson jabs work
By Sarah Pitt, Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
Thanks to the efforts of scientists, healthcare workers and trial participants around the world, a number of COVID-19 vaccines have now been authorised for general use. But while millions have been given a jab, billions still need to be vaccinated. We need to produce as many doses as we can.
So, it’s good news that two additional vaccines are on the horizon. Vaccine developers Novavax and Johnson & Johnson recently released data from the phase 3 clinical trials of their jabs,…
Read complete article
© The Conversation
- Wednesday, February 3rd 2021